Offering Nonclinical and Clinical Trial Support

Our nationally recognized team provides expertise in services spanning from basic research to advanced studies under FDA GLP regulations.

cro-hero-image-rev

Clinical Research Organization

We offer in vitro and in vivo studies testing vaccines, biologics and other test articles in therapeutic areas including infectious disease, central nervous system and cancer. Some of our accomplishments in moving science include:

  • Becoming the first CRO to offer preclinical efficacy testing and clinical trial support for COVID-19 vaccines
  • Serving as the first CRO to offer GLP support for high-path flu and Zika virus vaccine immunogenicity
  • Testing more than 90% of all HIV antivirals
  • Evaluating more than half of all anticancer drugs

Capabilities

bioanalytical-sciences-icon

Bioanalytical Sciences

oncology

Oncology

bacteriology_rev

Bacteriology

cell-biology-immunology-icon

Cell Biology & Immunology

infectious-disease-research-icon

Infectious Disease Research

pharmacokinetic-icon

Pharmacokinetic

toxicology-icon

Toxicology

Partner with Us

We have commercial, government, and industry partnership opportunities. Our work includes licensing patents, co-investing in furthering intellectual property, collaborating to create new intellectual property, and leveraging research to drive biotechnology product development.

CRO Services News

Southern Research breaks ground on new biotech center and campus renovations

Southern Research breaks ground on new biotech center and campus renovations

May 16, 2022 | Southern Research

Birmingham, Ala. – Southern Research today broke ground on a flagship biotech center that will anchor the development of 200,000 square feet of new or renovated wet lab space for life sciences. The new facility, located on the corner ...
Read More
Southern Research neuroscience lab wins grant for Parkinson’s, ALS research

Southern Research neuroscience lab wins grant for Parkinson’s, ALS research

July 14, 2021 | Southern Research

Rita Cowell is chair of Southern Research’s Neuroscience Department. A Southern Research neuroscience lab has received new federal grants totaling almost $3.9 million to advance its study of Parkinson’s Disease and other neurological diseases. The grants from the National Instit...
Read More
Southern Research and Tonix Pharmaceuticals Reports Positive COVID-19 Vaccine Efficacy Results

Southern Research and Tonix Pharmaceuticals Reports Positive COVID-19 Vaccine Efficacy Results

March 25, 2021 | Southern Research

Vaccine Candidate TNX-1800 Protected Both Upper and Lower Airways After Challenge with SARS-CoV-2, Suggesting an Ability to Block Forward Transmission   TNX-1800 is Based on a Proprietary Vaccine Platform Designed to Stimulate Long ...
Read More